Medical Market Report

Global Cancer Immunotherapy Market By Type (Monoclonal Antibodies, Immunomodulators, and Oncolytic Viral Therapies and Cancer Vaccines), By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer, and Pancreatic Cancer), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 138182
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global Cancer Immunotherapy Market is estimated to be valued US$ XX.X million in 2019. The report on Cancer Immunotherapy Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global cancer immunotherapy market is segmented on the basis of Type, Application, and geography.

    In 2019, the North America market is valued US$ XX.X million and the market share is estimated X.X%, and it is expected to be US$ XX.X million and X.X% in 2029, with a CAGR X.X% from 2020 to 2029.

    Cancer Immunotherapy Market Scope:

    By type, the market is segmented into Monoclonal Antibodies, Immunomodulators, and Oncolytic Viral Therapies and Cancer Vaccines. By Application, the market is divided into Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer, and Pancreatic Cancer.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Amgen Inc., AstraZeneca, F. Hoffmann La Roche Ltd., Bayer AG, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck and Co. Inc., Novartis AG, and Pfizer Inc..

    Key Market Segments

    Type

    Monoclonal Antibodies

    Immunomodulators

    Oncolytic Viral Therapies and Cancer Vaccines

    Application

    Lung Cancer

    Breast Cancer

    Colorectal Cancer

    Melanoma

    Prostate Cancer

    Head and Neck Cancer

    Ovarian Cancer

    Pancreatic Cancer

    Key Market Players included in the report:

    Amgen Inc.

    AstraZeneca

    F. Hoffmann La Roche Ltd.

    Bayer AG

    Bristol-Myers Squibb Company

    Eli Lilly and Company

    Merck and Co. Inc.

    Novartis AG

    Pfizer Inc.

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Cancer Immunotherapy Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Cancer Immunotherapy Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Cancer Immunotherapy Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Cancer Immunotherapy Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Cancer Immunotherapy Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Cancer Immunotherapy Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Cancer Immunotherapy sub-markets, depending on key regions (various vital states).
    To analyze Cancer Immunotherapy Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Cancer Immunotherapy Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide Cancer Immunotherapy Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Cancer Immunotherapy Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope
    

    2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players
    

    3. Global Cancer Immunotherapy Market Overview
    

    3.1. Cancer Immunotherapy Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges
    

      3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy
    

    4. Global Cancer Immunotherapy Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Cancer Immunotherapy Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Monoclonal Antibodies
    

      4.4. Immunomodulators
    

      4.5. Oncolytic Viral Therapies and Cancer Vaccines
    

    5. Global Cancer Immunotherapy Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Cancer Immunotherapy Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Lung Cancer
    

      5.4. Breast Cancer
    

      5.5. Colorectal Cancer
    

      5.6. Melanoma
    

      5.7. Prostate Cancer
    

      5.8. Head and Neck Cancer
    

      5.9. Ovarian Cancer
    

      5.10. Pancreatic Cancer
    

    6. Global Cancer Immunotherapy Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Cancer Immunotherapy Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Cancer Immunotherapy Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Cancer Immunotherapy Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Cancer Immunotherapy Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Cancer Immunotherapy Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    

    7. Global Cancer Immunotherapy Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Amgen#Inc.
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments
    

      7.4. AstraZeneca
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments
    

      7.5. F. Hoffmann La Roche Ltd.
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments
    

      7.6. Bayer AG
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments
    

      7.7. Bristol-Myers Squibb Company
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments
    

      7.8. Eli Lilly and Company
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments
    

      7.9. Merck and Co.#Inc.
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments
    

      7.10. Novartis AG
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments
    

      7.11. Pfizer#Inc.
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.